@article{9180d1f3a93641a3a65bf983c9fa46d0,
title = "Principles of haemophilia care: The asia pacific perspective. Response",
author = "S. Dunkley and Lam, \{J. C.M.\} and John, \{M. J.\} and Wong, \{R. S.M.\} and H. Tran and R. Yang and Nair, \{S. C.\} and M. Shima and A. Street and A. Srivastava",
note = "Funding Information: SD has received honoraria from Shire, Pfizer, Novo Nordisk and Bayer. JCML has received honoraria from Shire and is a study investigator for clinical trials sponsored by Shire and Bayer. RSMW has received sponsorship from Shire for attending symposiums and has been study investigator for research related haemophilia treatment funded by Biogen-Idec and Baxalta. HT has received speaker honorarium from Baxalta, Novonordisk, Bayer and Pfizer. MS is a board member of the Feiba and Advate Safety Board in Japan organized by Baxalta, received payment for consultancy meetings with Baxalta, Pfizer, Biogen, Bayer, CSL, Behring, Kaketsuken, Chugai Therapeutic Company and Novo Nordisk and received unrestricted grants supporting research from Baxalta, Pfizer, Bayer, Kaketsiken, Novo Nordisk, Chugai Pharmaceutical Company and CSL Behring. AS received grant support from Bayer, Shire, Novo Nordisk and Alnylam and has served on the DMC of LFB and Roche-Genentech studies. MJJ, SCN, RY, AS, have nothing to disclose. Copyright: Copyright 2019 Elsevier B.V., All rights reserved.",
year = "2018",
month = jul,
doi = "10.1111/hae.13522",
language = "English",
volume = "24",
pages = "e243--e244",
journal = "Haemophilia",
issn = "1351-8216",
publisher = "Wiley-Blackwell",
number = "4",
}